Although the VEGFR pathway is described as being central to the progression of retinal disorders, the TIE2 receptor pathway (the target for angiopoietin-2 [ANG2] and angiopoietin-1 [ANG1]) constitutes another component of the vascular development system.1 Here, ANGPT1 is linked to retinal disorder.